4.6 Review

Human alcohol-related neuropathology

期刊

ACTA NEUROPATHOLOGICA
卷 127, 期 1, 页码 71-90

出版社

SPRINGER
DOI: 10.1007/s00401-013-1233-3

关键词

-

资金

  1. National Institutes of Health [AA-11431, AA-12908, AA-12725]

向作者/读者索取更多资源

Alcohol-related diseases of the nervous system are caused by excessive exposures to alcohol, with or without co-existing nutritional or vitamin deficiencies. Toxic and metabolic effects of alcohol (ethanol) vary with brain region, age/developmental stage, dose, and duration of exposures. In the mature brain, heavy chronic or binge alcohol exposures can cause severe debilitating diseases of the central and peripheral nervous systems, and skeletal muscle. Most commonly, long-standing heavy alcohol abuse leads to disproportionate loss of cerebral white matter and impairments in executive function. The cerebellum (especially the vermis), cortical-limbic circuits, skeletal muscle, and peripheral nerves are also important targets of chronic alcohol-related metabolic injury and degeneration. Although all cell types within the nervous system are vulnerable to the toxic, metabolic, and degenerative effects of alcohol, astrocytes, oligodendrocytes, and synaptic terminals are major targets, accounting for the white matter atrophy, neural inflammation and toxicity, and impairments in synaptogenesis. Besides chronic degenerative neuropathology, alcoholics are predisposed to develop severe potentially life-threatening acute or subacute symmetrical hemorrhagic injury in the diencephalon and brainstem due to thiamine deficiency, which exerts toxic/metabolic effects on glia, myelin, and the microvasculature. Alcohol also has devastating neurotoxic and teratogenic effects on the developing brain in association with fetal alcohol spectrum disorder/fetal alcohol syndrome. Alcohol impairs function of neurons and glia, disrupting a broad array of functions including neuronal survival, cell migration, and glial cell (astrocytes and oligodendrocytes) differentiation. Further progress is needed to better understand the pathophysiology of this exposure-related constellation of nervous system diseases and better correlate the underlying pathology with in vivo imaging and biochemical lesions.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Pediatrics

Neuroinflammation-Related Encephalopathy in an Infant Born Preterm Following Exposure to Maternal Diabetic Ketoacidois

David E. Mandelbaum, Amanda Arsenault, Barbara S. Stonestreet, Stefan Kostadinov, Suzanne M. De La Monte

JOURNAL OF PEDIATRICS (2018)

Article Geriatrics & Gerontology

Blood-Cerebrospinal Fluid Barrier Gradients in Mild Cognitive Impairment and Alzheimer's Disease: Relationship to Inflammatory Cytokines and Chemokines

Brian R. Ott, Richard N. Jones, Lori A. Daiello, Suzanne M. de la Monte, Edward G. Stopa, Conrad E. Johanson, Charles Denby, Paula Grammas

FRONTIERS IN AGING NEUROSCIENCE (2018)

Article Clinical Neurology

The relationship between the morphological subtypes of microglia and Alzheimer's disease neuropathology

Patrick Jarmo Paasila, Danielle Suzanne Davies, Jillian June Kril, Claire Goldsbury, Greg Trevor Sutherland

BRAIN PATHOLOGY (2019)

Review Biochemistry & Molecular Biology

Recent Developments in TSPO PET Imaging as A Biomarker of Neuroinflammation in Neurodegenerative Disorders

Eryn L. Werry, Fiona M. Bright, Olivier Piguet, Lars M. Ittner, Glenda M. Halliday, John R. Hodges, Matthew C. Kiernan, Clement T. Loy, Jillian J. Kril, Michael Kassiou

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)

Letter Clinical Neurology

Are mutations in MAPT associated with GGT type III?

S. L. Forrest, G. M. Halliday, C. E. Shepherd, J. B. Kwok, M. Hallupp, J. J. Kril

NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2020)

Article Clinical Neurology

Globular glial tauopathy with a mutation in MAPT and unusual TDP-43 proteinopathy in a patient with behavioural-variant frontotemporal dementia

Shelley L. Forrest, Claire E. Shepherd, Heather McCann, John B. Kwok, Glenda M. Halliday, Jillian J. Kril

ACTA NEUROPATHOLOGICA (2021)

Article Biochemistry & Molecular Biology

Distribution Patterns of Astrocyte Populations in the Human Cortex

Shelley L. Forrest, Jordan Hanxi Kim, Daniel R. Crockford, Katharine Huynh, Rosie Cheong, Samantha Knott, Madison A. Kane, Lars M. Ittner, Glenda M. Halliday, Jillian J. Kril

Summary: This study maps the distribution and density of astrocytes in the human frontal cortex, revealing distinct and overlapping populations of astrocytes. The findings provide a reference map for comparative studies in various disease and injury states involving astrocytes.

NEUROCHEMICAL RESEARCH (2023)

Letter Clinical Neurology

Riluzole is associated with decreasing neuritic plaque severity in amyotrophic lateral sclerosis

Srestha Mazumder, Heather McCann, Susan D'Silva, Sarah Furlong, Claire E. Shepherd, Jillian J. Kril, Glenda M. Halliday, Dominic B. Rowe, Matthew C. Kiernan, Rachel H. Tan

Article Clinical Neurology

Treatment with the copper compound CuATSM has no significant effect on motor neuronal pathology in patients with ALS

Yue Yang, Dominic Rowe, Heather McCann, Claire E. Shepherd, Jillian J. Kril, Matthew C. Kiernan, Glenda M. Halliday, Rachel H. Tan

Summary: This study compared the pathology of ALS patients who received CuATSM and riluzole with those who only received riluzole, and found no significant difference in neuron density or TDP-43 burden. However, CuATSM treatment led to the presence of p62-immunoreactive astrocytes in the motor cortex and reduced Iba1 density in the spinal cord. There was no significant difference in astrocytic activity and SOD1 immunoreactivity with CuATSM treatment.

NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2023)

Article Biochemistry & Molecular Biology

Concordant and Discordant Cerebrospinal Fluid and Plasma Cytokine and Chemokine Responses in Mild Cognitive Impairment and Early-Stage Alzheimer's Disease

Suzanne M. de la Monte, Ming Tong, Andrew J. Hapel

Summary: Neuroinflammation may serve as a pathogenic mediator and biomarker of neurodegeneration in the transition between mild cognitive impairment (MCI) and early-stage Alzheimer's disease (AD). This study suggests that early management of MCI/AD neuroinflammation should involve both anti-inflammatory and pro-neuroprotective strategies.

BIOMEDICINES (2023)

Article Nutrition & Dietetics

Myriocin Treatment Reverses Alcohol-Induced Alterations in Polyunsaturated Fatty Acid-Containing Phospholipid Expression in the Liver

Emine B. Yalcin, Ming Tong, Camilla Homans, Suzanne M. de la Monte

Summary: Chronic heavy alcohol exposure can cause alcoholic liver disease, but it can be improved by using the serine palmitoyltransferase inhibitor myriocin, which may regulate the composition of hepatic phospholipids containing docosahexaenoic acid and arachidonic acid.

NUTRITION AND METABOLIC INSIGHTS (2022)

Article Pediatrics

Neuropathologic Findings in a Child with a Novel Variant of TBCK-Related Encephaloneuronopathy

Sonja Chen, Fouad Zakkat, Salwa Khedrt, Shamlal Mangrayt, Lauren Massingham, Suzanne M. de la Monte

JOURNAL OF PEDIATRIC NEUROLOGY (2020)

Article Medicine, Research & Experimental

Critical Shifts in Cerebral White Matter Lipid Profiles After Ischemic-Reperfusion Brain Injury in Fetal Sheep as Demonstrated by the Positive Ion Mode MALDI-Mass Spectrometry

Suzanne M. de la Monte, Gina M. Gallucci, Amy Lin, Ming Tong, Xiaodi Chen, Barbara S. Stonestreet

CELL MEDICINE (2020)

Meeting Abstract Substance Abuse

ACCURATE MASS MALDI-TOF/ TOF LIPID IMAGING OF HUMAN BRAIN TISSUE

C. C. Smith, M. B. O'Rourke, M. Padula, S. M. De La Monte, D. L. Sheedy, J. J. Kril, G. T. Sutherland

ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH (2018)

暂无数据